CorMedix Acquires Heron Assets
CorMedix announced the acquisition of substantially all of Heron Therapeutics' assets via a definitive asset purchase agreement. This is an M&A transaction expected to create synergies and be accretive to earnings and free cash flow.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed